Status: Recruiting
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
An investigator-blinded, randomized, multicenter, active-controlled Phase III study for the treatment of anemia in patients with CKD on hemodialysis
Participants needed: 429
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Genexine, Inc.Updated: May 22, 2026Locations: 58
Eligibility criteria
Adult males and females ≥ 18 years old. [+12]
Active acute or chronic infection, or uncontrolled or symptomatic inflammatory d... [+27]